Concepts (66)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2020 | 7868 | 0.58 | Why? |
| Immunoassay | 2 | 2021 | 4485 | 0.56 | Why? |
| Antibodies, Viral | 7 | 2021 | 51949 | 0.33 | Why? |
| Immunoglobulin A | 4 | 2021 | 3567 | 0.23 | Why? |
| Sensitivity and Specificity | 4 | 2021 | 22971 | 0.16 | Why? |
| Candidemia | 1 | 2020 | 353 | 0.15 | Why? |
| Kinetics | 2 | 2021 | 3238 | 0.15 | Why? |
| Immunoglobulin M | 3 | 2021 | 9091 | 0.14 | Why? |
| Austria | 3 | 2021 | 1259 | 0.12 | Why? |
| Crohn Disease | 1 | 2021 | 959 | 0.11 | Why? |
| Colitis, Ulcerative | 1 | 2021 | 1037 | 0.11 | Why? |
| Immunoglobulin G | 5 | 2021 | 21571 | 0.11 | Why? |
| Nasopharynx | 2 | 2020 | 10224 | 0.11 | Why? |
| Phosphoproteins | 1 | 2021 | 4346 | 0.10 | Why? |
| Immunity, Humoral | 1 | 2021 | 4849 | 0.08 | Why? |
| Serologic Tests | 1 | 2020 | 4359 | 0.08 | Why? |
| Polymerase Chain Reaction | 1 | 2020 | 6740 | 0.07 | Why? |
| Immunocompromised Host | 1 | 2021 | 5150 | 0.07 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.06 | Why? |
| Immunosuppressive Agents | 1 | 2021 | 6331 | 0.06 | Why? |
| Disease Management | 1 | 2020 | 6841 | 0.06 | Why? |
| Seroepidemiologic Studies | 3 | 2021 | 10017 | 0.05 | Why? |
| Time Factors | 2 | 2021 | 31397 | 0.05 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.05 | Why? |
| Secondary Care | 1 | 2020 | 160 | 0.05 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.05 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.05 | Why? |
| Young Adult | 5 | 2021 | 93724 | 0.05 | Why? |
| Aged | 6 | 2021 | 215776 | 0.05 | Why? |
| Middle Aged | 7 | 2021 | 270681 | 0.05 | Why? |
| Male | 9 | 2021 | 367725 | 0.05 | Why? |
| Adolescent | 4 | 2021 | 86841 | 0.04 | Why? |
| Critical Illness | 1 | 2021 | 17281 | 0.04 | Why? |
| Physicians, Primary Care | 1 | 2020 | 298 | 0.04 | Why? |
| Humans | 13 | 2021 | 930598 | 0.04 | Why? |
| Tomography, X-Ray Computed | 2 | 2020 | 25144 | 0.04 | Why? |
| Female | 7 | 2021 | 380317 | 0.04 | Why? |
| Immunization, Passive | 2 | 2021 | 10067 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 2021 | 2324 | 0.03 | Why? |
| Aged, 80 and over | 2 | 2021 | 88759 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.03 | Why? |
| Adult | 4 | 2021 | 244371 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.03 | Why? |
| Antifungal Agents | 1 | 2020 | 1828 | 0.02 | Why? |
| Blood Donors | 1 | 2020 | 2956 | 0.02 | Why? |
| Prospective Studies | 2 | 2021 | 43301 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2020 | 9537 | 0.02 | Why? |
| Antibodies, Neutralizing | 2 | 2021 | 25288 | 0.02 | Why? |
| Tertiary Care Centers | 1 | 2021 | 8248 | 0.02 | Why? |
| Child | 2 | 2021 | 70012 | 0.01 | Why? |
| Pandemics | 4 | 2020 | 389249 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2021 | 11041 | 0.01 | Why? |
| Coinfection | 1 | 2020 | 6820 | 0.01 | Why? |
| Incidence | 1 | 2021 | 25622 | 0.01 | Why? |
| Hypertension | 1 | 2020 | 8895 | 0.01 | Why? |
| Biomarkers | 1 | 2021 | 23361 | 0.01 | Why? |
| Cohort Studies | 1 | 2021 | 36005 | 0.01 | Why? |
| Child, Preschool | 1 | 2021 | 36283 | 0.01 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.01 | Why? |
| Treatment Outcome | 1 | 2020 | 51732 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2021 | 53120 | 0.01 | Why? |
| Infection Control | 1 | 2021 | 23131 | 0.01 | Why? |
| Communicable Disease Control | 1 | 2021 | 29620 | 0.01 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.01 | Why? |
| Retrospective Studies | 1 | 2021 | 105322 | 0.01 | Why? |